Armando Anido
2014
In 2014, Armando Anido earned a total compensation of $1M as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals.
Compensation breakdown
| Salary | $114,855 |
|---|---|
| Stock Awards | $794,580 |
| Other | $102,702 |
| Total | $1,012,167 |
Anido received $794.6K in stock awards, accounting for 79% of the total pay in 2014.
Anido also received $114.9K in salary and $102.7K in other compensation.
Rankings
In 2014, Armando Anido's compensation ranked 7,555th out of 13,032 executives tracked by ExecPay. In other words, Anido earned more than 42.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,555 out of 13,032 | 42nd |
Division Manufacturing | 2,791 out of 4,965 | 44th |
Major group Chemicals And Allied Products | 948 out of 1,690 | 44th |
Industry group Drugs | 745 out of 1,369 | 46th |
Industry Pharmaceutical Preparations | 577 out of 1,042 | 45th |
Source: SEC filing on April 13, 2016.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2014.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019